STOCK TITAN
  1. Home
  2. News
  3. ELAN

Elanco Animal Health Incorporated - ELAN STOCK NEWS

Welcome to our dedicated page for Elanco Animal Health Incorporated news (Ticker: ELAN), a resource for investors and traders seeking the latest updates and insights on Elanco Animal Health Incorporated stock.

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health, committed to innovating and delivering products and services to improve the health and wellness of both farm animals and pets. Established with nearly 70 years of heritage, Elanco operates in over 90 countries with a diverse portfolio of approximately 200 brands. Their core mission is encapsulated in their vision: 'Food and Companionship Enriching Life,' which they pursue through three primary avenues:

  • Enhancing food security by improving the health and productivity of farm animals, thereby contributing to a safer, more affordable, and abundant food supply.
  • Helping pets live longer, healthier lives through advanced veterinary products.
  • Improving food safety standards globally.

Elanco’s dedication to animal health is reflected in their continuous innovation and quality systems, driven by a shared vision of enhancing life for animals and humans alike. This commitment is evident in their recent achievements and ongoing projects. For instance, Elanco's collaboration with Agtech company, Cattler, aims to provide data-driven solutions to cattle farmers, enhancing operational efficiency and productivity through services like Benchmark™ and Experior™.

Elanco's financial health is strong, with the company reporting consistent revenue growth and strategic investments aimed at future expansion. In their recent financial results, Elanco posted a 5% growth in the fourth quarter and strengthened their commercial infrastructure to support ongoing and future growth. They also announced the divestiture of their aqua business to streamline operations and focus on core areas, which is expected to reduce their debt leverage significantly by year-end.

Environmental sustainability is another critical focus for Elanco. Their recent partnership with Athian to create a livestock carbon insetting marketplace is a significant step towards reducing greenhouse gas emissions in the dairy and beef industries. Products like Bovaer®, which significantly reduce methane emissions from cattle, exemplify Elanco's commitment to sustainable farming practices.

Overall, Elanco continues to be at the forefront of animal health innovation, with substantial investments in R&D, strategic partnerships, and a clear commitment to sustainability and community health.

News

Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement

Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE: ELAN) has confirmed the date for its first quarter 2024 financial results announcement and conference call. The announcement will take place on May 8, 2024, with a conference call scheduled for 8:00 a.m. eastern time on the same day. Investors, media, and the general public can access a live webcast of the call on Elanco's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.69%
Tags
earnings
-
News

Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors

Rhea-AI Summary
Elanco Animal Health Incorporated appoints two new independent directors, Kathy Turner and Craig Wallace, expanding the Board to 14 members. The Board's Finance, Strategy and Oversight Committee is renamed. Elanco reaches a cooperation agreement with Ancora Holdings Group
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
management
-
News

The Cow is the How: Elanco Sees Methane Reduction as New Value Opportunity

Rhea-AI Summary
Elanco Animal Health CEO, Jeff Simmons, discusses the company's commitment to sustainability by reducing cattle emissions, particularly methane, on Mad Money with Jim Cramer. Elanco aims to pioneer solutions for farmers that can create new value and climate-neutral farms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.11%
Tags
none
News

Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary

Rhea-AI Summary
Elanco Animal Health appoints Shiv O'Neill as Executive Vice President, General Counsel, and Corporate Secretary, bringing over 20 years of legal expertise to lead the company's legal team and support growth objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
management
-
News

Elanco Animal Health is Executing on Plan to Deliver for Shareholders

Rhea-AI Summary
Elanco Animal Health Incorporated (ELAN) responds to Ancora Holdings Group, LLC's nomination of director candidates despite Elanco's operational progress and engagement efforts. Elanco's CEO Jeff Simmons leads the successful execution of the Innovation, Portfolio, and Productivity strategy, resulting in growth and a promising pipeline. Shareholders have seen a 39% stock increase in the past year, surpassing industry peers. While Elanco welcomes shareholder engagement, Ancora's demands for Board changes are met with resistance. Elanco has made strategic moves to improve performance, including divesting the aqua business and enhancing corporate governance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
none
-
News

Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results

Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE: ELAN) reported fourth quarter and full year 2023 financial results, with revenue of $1,035 million and $4,417 million respectively. The company announced a strategic restructuring impacting approximately 420 personnel to generate savings and reinvest in value creation opportunities. Full year 2024 guidance includes revenue of $4,450 to $4,540 million and adjusted EBITDA of $960 to $1,010 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
earnings
News

Elanco to Participate in Upcoming Investor Conferences

Rhea-AI Summary
Elanco Animal Health Incorporated (ELAN) to participate in upcoming investor conferences, featuring key executives in fireside chats at major events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
conferences
-
News

Athian and Elanco Animal Health Team Up to Transform Food Production through Methane Reduction

Rhea-AI Summary
Athian announces the establishment of a livestock carbon insetting marketplace with the first carbon credits verified for sale, in collaboration with Elanco Animal Health. This initiative aims to reduce enteric methane emissions and improve feed utilization, offering dairy farmers the opportunity to monetize their greenhouse gas emission reductions. The marketplace enables companies in the dairy value chain to purchase carbon credits to support their emissions reduction goals, while returning economic value to farmers. Elanco's UpLook tool helps farmers measure and monitor greenhouse gas emissions, further enhancing sustainability efforts. This innovative marketplace addresses the challenge of reducing Scope 3 emissions in the animal protein value chain, providing a significant opportunity for companies to achieve their sustainability goals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.63%
Tags
none
-
News

Beef 'agtech' company Cattler launches interface with Elanco for its Benchmark program

Rhea-AI Summary
Cattler, an agtech company, has launched an interface with Elanco Animal Health Incorporated as part of their agreement to provide data collaboration for customers participating in Elanco Knowledge Solutions services. This partnership aims to provide Cattler customers with streamlined access to Elanco's data services and products, allowing cattle feeders to optimize their practices and gain actionable insights. The interface will provide global cattle producers with access to Elanco's Benchmark and Experior Data Services, enhancing the producer's experience with the Cattler platform. Elanco's Benchmark program is designed to convert data into information to help cattle feeders identify strengths and opportunities to pursue and measure performance over time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
none
News

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2023 Financial Results Announcement

Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE: ELAN) is set to announce its fourth quarter and full year 2023 financial results on February 26, 2024. The company will also conduct a conference call to discuss its performance, which will be accessible to investors, media, and the general public via a live webcast on Elanco's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
earnings

FAQ

What is the current stock price of Elanco Animal Health Incorporated (ELAN)?

The current stock price of Elanco Animal Health Incorporated (ELAN) is $13.98 as of November 15, 2024.

What is the market cap of Elanco Animal Health Incorporated (ELAN)?

The market cap of Elanco Animal Health Incorporated (ELAN) is approximately 6.8B.

What is Elanco Animal Health's core mission?

Elanco's core mission is encapsulated in their vision: 'Food and Companionship Enriching Life,' which they pursue by enhancing food security, improving pet health, and elevating food safety standards globally.

In how many countries does Elanco operate?

Elanco operates in over 90 countries worldwide.

What recent collaborations has Elanco engaged in?

Elanco recently collaborated with Agtech company Cattler to provide data-driven solutions to cattle farmers through services like Benchmark™ and Experior™.

What is the significance of Elanco's partnership with Athian?

The partnership with Athian aims to create a livestock carbon insetting marketplace, reducing greenhouse gas emissions and promoting sustainable farming practices.

What are some of Elanco's notable products?

Elanco's notable products include Seresto®, Experior™, and Bovaer®, the latter being a methane-reducing feed ingredient for cattle.

How is Elanco addressing sustainability in animal farming?

Elanco addresses sustainability through innovative products like Bovaer®, which reduces methane emissions from cattle, and partnerships aimed at creating carbon insetting marketplaces.

What financial goals has Elanco set for 2024?

Elanco expects constant currency revenue growth of 2% to 3% for 2024, driven by new product launches and operational improvements. They also anticipate significant debt reduction through strategic divestitures.

How does Elanco contribute to food safety?

Elanco contributes to food safety by developing products that improve the health and performance of farm animals, thereby ensuring a safer and more reliable food supply.

What is Elanco's approach to innovation?

Elanco's approach to innovation involves continuous R&D investments, strategic partnerships, and the development of new products that address pressing issues in animal health and sustainability.

How does Elanco support the health and wellness of pets?

Elanco supports pet health through an extensive range of veterinary products designed to improve the quality and longevity of pets' lives.

Stock ELAN logo
Elanco Animal Health Incorporated

NYSE:ELAN

ELAN Rankings

#1087 Ranked by Market Cap
N/A Ranked by Dividends

ELAN Stock Data

6.81B
494.35M
0.66%
100.35%
2.33%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
GREENFIELD